Overview

The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A

Status:
Not yet recruiting
Trial end date:
2023-09-10
Target enrollment:
Participant gender:
Summary
A study to evaluate the pharmacokinetics, pharmacodynamics, and safety of CKD-843 A in male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical